Implementation Guidelines - Federal Transit Administration - U.S. ...

⎯ Direct the analysis of the split specimen if he/she concludes that
there is legitimate explanation for the employee’s failure to
contact the MRO within 72 hours? If the MRO concludes that
there is no legitimate explanation for the employee’s failure to
contact the MRO within 72 hours, then the MRO is not required
to direct the analysis of the split specimen to be performed.
⎯ Maintain all necessary records and send test result reports to the
transit agency’s drug and alcohol program manager.
⎯ Protect the employees’ privacy and testing program
confidentiality.
Are procedures in place for disclosure of verified positive test results to
the employer and the confidentiality that is required for medical
information not specifically related to the use of drugs?
⎯ If any quantitative results are given in the lab report, the
employer is not authorized to receive such quantitative results
and they should not be transmitted by the MRO to the employer.
Does the Medical Review Officer transmit all test results in a timely and
secure manner? Results must be transmitted the same day they are
verified or the next business day.
Does the Medical Review Officer know the procedure for dealing with
adulterated, diluted, and “unsuitable for testing” specimens?
⎯ If a specimen is adulterated or substituted:
⎯ The donor has a right to a split specimen test.
⎯ The donor has the right to discuss the result with the
MRO and provide evidence that supports how the test
results could be obtained legitimately through
physiological means.
⎯ If the MRO is not satisfied with the explanation or
evidence provided, these specimens will be reported to
employers as a “refusal to test.”
Does the MRO have a copy of the DOT Medical Review Officer
Guidelines?
Does the MRO know when no-contact test results can be verified
positive?
Appendix J. Self-Assessment Checklist J-17 August 2002
DRUG TESTING
PROCEDURES
Medical Review
Officer